Affinity Asset Advisors, LLC Q1 2022 Filing
Filed May 13, 2022
Portfolio Value
$625.0B
Holdings
56
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (56 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 750,000 | $338.7B | 54.19% | Put |
| 2 | SWTXSPRINGWORKS THERAPEUTICS INC | 407,000 | $23.0B | 3.68% | Put |
| 3 | NARIUSDINARI MED INC | 220,000 | $19.9B | 3.19% | |
| 4 | MORFMORPHIC HLDG INC | 465,654 | $18.7B | 2.99% | |
| 5 | KURAKURA ONCOLOGY INC | 924,147 | $14.9B | 2.38% | |
| 6 | ASNDASCENDIS PHARMA A/S | 120,000 | $14.1B | 2.25% | |
| 7 | 290ACHINOOK THERAPEUTICS INC | 845,155 | $13.8B | 2.21% | |
| 8 | PTGXPROTAGONIST THERAPEUTICS INC | 515,900 | $12.2B | 1.95% | Put |
| 9 | ESTAESTABLISHMENT LABS HLDGS INC | 174,500 | $11.8B | 1.88% | |
| 10 | TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | 11,000,000 | $11.5B | 1.84% | |
| 11 | AZNASTRAZENECA PLC | 160,000 | $10.6B | 1.70% | |
| 12 | ZNTLZENTALIS PHARMACEUTICALS INC | 207,500 | $9.6B | 1.53% | |
| 13 | LNTHLANTHEUS HLDGS INC | 155,000 | $8.6B | 1.37% | Put |
| 14 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 7,000,000 | $7.8B | 1.24% | |
| 15 | MDGLMADRIGAL PHARMACEUTICALS INC | 75,000 | $7.4B | 1.18% | |
| 16 | —ARYA SCIENCES ACQUISITN CORP | 702,500 | $6.8B | 1.09% | |
| 17 | RPTXREPARE THERAPEUTICS INC | 468,905 | $6.7B | 1.07% | |
| 18 | PMVPPMV PHARMACEUTICALS INC | 317,400 | $6.6B | 1.06% | Call |
| 19 | NSTGEURNANOSTRING TECHNOLOGIES INC | 171,592 | $6.0B | 0.95% | |
| 20 | —VINCERX PHARMA INC | 1,374,098 | $5.5B | 0.88% | |
| 21 | RCKTROCKET PHARMACEUTICALS INC | 300,000 | $4.8B | 0.76% | |
| 22 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 10,000,000 | $4.7B | 0.75% | |
| 23 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 7,500,000 | $4.4B | 0.70% | |
| 24 | TCE2CELLDEX THERAPEUTICS INC NEW | 125,000 | $4.3B | 0.68% | |
| 25 | BLUBELLUS HEALTH INC NEW | 600,000 | $4.1B | 0.66% | |
| 26 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,272,244 | $4.0B | 0.63% | |
| 27 | CRSPCRISPR THERAPEUTICS AG | 55,000 | $3.5B | 0.55% | Call |
| 28 | HZNPHORIZON THERAPEUTICS PUB L | 30,000 | $3.2B | 0.50% | |
| 29 | —HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3.0B | 0.48% | |
| 30 | —MEDICUS SCIENCES ACQUISITION | 300,000 | $2.9B | 0.47% | |
| 31 | TVTXTRAVERE THERAPEUTICS INC | 100,000 | $2.6B | 0.41% | |
| 32 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 70,000 | $2.5B | 0.39% | |
| 33 | XENEXENON PHARMACEUTICALS INC | 80,000 | $2.4B | 0.39% | |
| 34 | NAUTNAUTILUS BIOTECHNOLOGY INC | 559,019 | $2.4B | 0.39% | |
| 35 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 70,000 | $2.4B | 0.39% | |
| 36 | RLAYRELAY THERAPEUTICS INC | 75,000 | $2.2B | 0.36% | Call |
| 37 | AUPHAURINIA PHARMACEUTICALS INC | 175,000 | $2.2B | 0.35% | Call |
| 38 | ACRSACLARIS THERAPEUTICS INC | 100,000 | $1.7B | 0.28% | |
| 39 | BEAMBEAM THERAPEUTICS INC | 30,000 | $1.7B | 0.28% | Call |
| 40 | CNTXCONTEXT THERAPEUTICS INC | 777,610 | $1.7B | 0.27% | |
| 41 | —CYCLACEL PHARMACEUTICALS INC | 400,000 | $1.2B | 0.20% | |
| 42 | LIANYLIANBIO | 325,000 | $1.2B | 0.19% | |
| 43 | —SCIENCE 37 HOLDINGS INC | 221,382 | $1.2B | 0.19% | |
| 44 | KRTXKARUNA THERAPEUTICS INC | 7,500 | $951.0M | 0.15% | |
| 45 | VRDNVIRIDIAN THERAPEUTICS INC | 50,000 | $925.0M | 0.15% | |
| 46 | —ATHERSYS INC NEW | 1,416,400 | $858.0M | 0.14% | Put |
| 47 | —RENOVACOR INC | 199,490 | $846.0M | 0.14% | |
| 48 | —CURIS INC | 350,000 | $833.0M | 0.13% | |
| 49 | CELUCELULARITY INC | 80,000 | $697.0M | 0.11% | Put |
| 50 | CNTACENTESSA PHARMACEUTICALS PLC | 65,282 | $586.0M | 0.09% | |
| 51 | —CALITHERA BIOSCIENCES INC | 1,000,000 | $404.0M | 0.06% | |
| 52 | IMTXIMMATICS N.V | 187,204 | $328.0M | 0.05% | |
| 53 | HYPRHYPERFINE INC | 76,162 | $270.0M | 0.04% | |
| 54 | 2L9BLUEPRINT MEDICINES CORP | 1,988 | $127.0M | 0.02% | |
| 55 | —RENOVACOR INC | 75,000 | $26.0M | 0.00% | |
| 56 | —MEDICUS SCIENCES ACQUISITION | 33,333 | $14.0M | 0.00% |